NantKwest, Inc. Contracts & Agreements

Settlement Agreement and Release dated July 13, 2024 entered into by and among Altor BioScience, LLC, NantCell, Inc., HCW Biologics, Inc., and Dr. Hing C. Wong (Filed With SEC on November 12, 2024)

ImmunityBio, Inc. 2015 Equity Incentive Plan (Filed With SEC on August 12, 2024)

ImmunityBio, Inc. 2015 Equity Incentive Plan (Filed With SEC on May 9, 2024)

Description of Registrants Securities (Filed With SEC on March 19, 2024)

Revenue Interest Purchase Agreement dated as of December 29, 2023 among ImmunityBio, Inc., the Purchasers from time to time party hereto and Infinity SA LLC (Filed With SEC on March 19, 2024)

Security and Pledge Agreement as of December 29, 2023 among ImmunityBio, Inc., the Subsidiary Guarantors listed on the signature pages hereto, such other parties that may become... (Filed With SEC on March 19, 2024)

Stock Purchase and Option Agreement dated December 29, 2023 by and between the Investors and ImmunityBio, Inc (Filed With SEC on March 19, 2024)

Letter Amendment dated December 29, 2023 to the Convertible Promissory Notes dated March 31, 2023 (as amended on September 11, 2023) and September 30, 2023 issued by ImmunityBio,... (Filed With SEC on March 19, 2024)

Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated December 29, 2023 (Filed With SEC on March 19, 2024)

Extension of Commercial Lease by and between Duley Road, LLC and Altor BioScience Manufacturing Company, LLC, dated October 3, 2023 (Filed With SEC on March 19, 2024)

Amended Form of February 2023 Common Stock Purchase Warrant (Filed With SEC on November 9, 2023)

Lease Termination Agreement (Filed With SEC on November 9, 2023)

Stock Purchase Agreement (Filed With SEC on November 9, 2023)

Convertible Promissory Note dated (Filed With SEC on November 9, 2023)

Letter of Amendment dated (Filed With SEC on November 9, 2023)

Extension of Commercial Lease by and between 605 Doug St, LLC and ImmunityBio, Inc., dated June 30, 2023 (Filed With SEC on August 8, 2023)

Placement Agency Agreement by and between the Company and Jefferies LLC, dated as of July 20, 2023 (Filed With SEC on July 21, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on July 21, 2023)

Securities Purchase Agreement, dated as of July 20, 2023 (Filed With SEC on July 21, 2023)

Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated June 1 (Filed With SEC on June 14, 2023)

Convertible Promissory Note by and between the Company and Nant Capital, LLC dated as of March 31, 2023 (Filed With SEC on March 31, 2023)

Placement Agency Agreement by and between the Company and Jefferies, LLC, dated as of February 15, 2023 (Filed With SEC on February 15, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on February 15, 2023)

Securities Purchase Agreement dated as of February 15, 2023 (Filed With SEC on February 15, 2023)

Placement Agency Agreement by and between the Company and Piper Sandler & Co., dated as of December 12, 2022 (Filed With SEC on December 12, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on December 12, 2022)

Securities Purchase Agreement dated as of December 12, 2022 (Filed With SEC on December 12, 2022)

Promissory Note between the Company and Nant Capital, LLC dated December 12, 2022 (Filed With SEC on December 12, 2022)

Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantWorks, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantCancerStemCell, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantMobile, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amendment to Facility License Agreement, effective as of May 1, 2022, by and between NantWorks, LLC, the Licensor, and ImmunityBio, Inc., the Licensee (Filed With SEC on August 8, 2022)

Industrial/Commercial Lease Agreement dated May 1, 2022 by and between 23 Alaska, LLC and ImmunityBio, Inc (Filed With SEC on August 8, 2022)

First Amendment to Lease dated July 16, 2015 by and between ARE-JOHN HOPKINS COURT, LLC and Conkwest, Inc (Filed With SEC on August 8, 2022)

Second Amendment to Lease effective as of June 18, 2016 by and between ARE-JOHN HOPKINS COURT, LLC and NantKwest, Inc., fka Conkwest, Inc (Filed With SEC on August 8, 2022)

Third Amendment to Lease dated April 12, 2022 by and between ARE-JOHN HOPKINS COURT, LLC and ImmunityBio, Inc (Filed With SEC on August 8, 2022)

Lease Termination Agreement effective May 31, 2022 by and between ImmunityBio, Inc. and 557 Doug St., LLC (Filed With SEC on August 8, 2022)

Fort Schuyler Management Corporation Lease, effective as of October 1, 2021, between Fort Schuyler Management Corporation, as Landlord, and Athenex, Inc., as Tenant (Filed With SEC on May 10, 2022)

First Amendment to Lease, effective as of February 14, 2022, by and among Fort Schuyler Management Corporation and Immunity, Bio, Inc (Filed With SEC on May 10, 2022)

Description of Registrants Securities (Filed With SEC on March 1, 2022)

Offer Letter, dated October 12, 2021, by and among ImmunityBio, Inc. and Regan Lauer (Filed With SEC on March 1, 2022)

Purchase Agreement, by and between Athenex, Inc. and ImmunityBio, Inc. dated as of January 7, 2022 (Filed With SEC on January 12, 2022)

Promissory Note by and between the Company and Nant Capital, LLC dated as of December 17, 2021 (Filed With SEC on December 20, 2021)

Membership Interest Purchase Agreement entered into as of September 27, 2021, by and among Nant Capital, LLC and ImmunityBio, Inc (Filed With SEC on November 12, 2021)

Industrial/Commercial Lease Agreement, dated September 27, 2021, by and between 557 Doug St, LLC and ImmunityBio, Inc (Filed With SEC on November 12, 2021)

Commercial Lease Agreement, dated September 27, 2021 and made effective October 1, 2021, by and between 420 NASH, LLC and ImmunityBio, Inc (Filed With SEC on November 12, 2021)

First Amendment to Lease made and entered into as of May 28, 2021, but made effective as of April 1, 2021, by and between 605 Nash, LLC and ImmunityBio, Inc (Filed With SEC on August 12, 2021)

Open Market Sale Agreement dated April 30, 2021, by and between ImmunityBio, Inc. and Jefferies LLC (Filed With SEC on May 3, 2021)

ImmunityBio, Inc. (f/k/a NantKwest, Inc.) Amended Outside Director Compensation Policy (Filed With SEC on March 10, 2021)

Promissory Note, dated February 22, 2021, issued by NantCell, Inc. (f/k/a ImmunityBio, Inc.) to Nant Capital, LLC (Filed With SEC on March 10, 2021)

Lease Agreement between 605 Nash, LLC and NantKwest, Inc., dated February 11, 2021 (Filed With SEC on March 4, 2021)

Agreement and Plan of Merger, dated March 31, 2017, by and among ImmunityBio, Inc., Bio Merger Sub Inc., Liquid Genomics, Inc. and the Stockholder Representative thereunder (Filed With SEC on January 19, 2021)

Agreement and Plan of Merger, dated May 19, 2017, by and among ImmunityBio, Inc., Altor Acquisition LLC, Altor BioScience Corporation and Shareholder Representative Services LLC (Filed With SEC on January 19, 2021)

Agreement and Plan of Merger, dated May 15, 2018, by and among ImmunityBio, Inc., Receptome Acquisition Corporation, Receptome, Inc., and the Selling Stockholder thereunder (Filed With SEC on January 19, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantWorks, LLC (Filed With SEC on January 19, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantCancerStemCell, LLC (Filed With SEC on January 19, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantMobile, LLC (Filed With SEC on January 19, 2021)

Promissory Note, dated September 30, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)

FDA Milestone Contingent Value Rights Agreement, dated July 31, 2017, by and between ImmunityBio, Inc. and the Stockholder Representative thereunder (Filed With SEC on January 19, 2021)

Sales Milestone Contingent Value Rights Agreement, dated July 31, 2017, by and between ImmunityBio, Inc. and the Stockholder Representative thereunder (Filed With SEC on January 19, 2021)

Common Stock Purchase Warrant, dated June 30, 2016, issued by ImmunityBio, Inc. to NantWorks, LLC (Filed With SEC on January 19, 2021)

2015 Stock Incentive Plan of ImmunityBio, Inc., as amended, and forms of agreement thereunder (Filed With SEC on January 19, 2021)

Exclusive License Agreement, dated February 16, 2016, by and between NantBioScience, Inc. and Etubics Corporation (Filed With SEC on January 19, 2021)

Exclusive License Agreement, dated January 1, 2020, by and between ImmunityBio, Inc. and GlobeImmune, Inc (Filed With SEC on January 19, 2021)

Exclusive License Agreement, dated August 7, 2020, by and between ImmunityBio, Inc. and iosBio Ltd (Filed With SEC on January 19, 2021)

Assignment Agreement, dated July 31, 2017, by and between ImmunityBio, Inc. and NantOmics, LLC (Filed With SEC on January 19, 2021)

Shared Services Agreement, dated May 13, 2015, by and between ImmunityBio, Inc. and NantWorks, LLC (Filed With SEC on January 19, 2021)

Amendment #1 to Shared Services Agreement, dated January 1, 2016, by and between ImmunityBio, Inc. and NantWorks, LLC (Filed With SEC on January 19, 2021)

Supply Agreement, dated August 15, 2018, by and between ImmunityBio, Inc. and NantBio, Inc (Filed With SEC on January 19, 2021)

Shared Services Agreement, dated April 4, 2019, by and between ImmunityBio, Inc. and NantBio, Inc (Filed With SEC on January 19, 2021)

Assignment Agreement, dated July 2, 2017, by and between NantPharma, LLC and Immunotherapy NANTibody, LLC (Filed With SEC on January 19, 2021)

Letter Agreement, dated February 14, 2018, by and between NantPharma, LLC and Immunotherapy NANTibody, LLC (Filed With SEC on January 19, 2021)

Commercial Lease, dated February 1, 2017, by and between Duley Road, LLC and Altor BioScience Manufacturing Company, LLC (Filed With SEC on January 19, 2021)

Commercial Lease, dated January 28, 2019, by and between Duley Road, LLC and ImmunityBio, Inc (Filed With SEC on January 19, 2021)

Common Stock Purchase Agreement, dated April 30, 2018, by and among ImmunityBio, Inc. and NantBio, Inc (Filed With SEC on January 19, 2021)

Offer Letter, dated August 3, 2020, by and among ImmunityBio, Inc. and David Sachs (Filed With SEC on January 19, 2021)

Agreement and Plan of Merger, dated December 21, 2020, by and among NantKwest, Inc., ImmunityBio, Inc. and Nectarine Merger Sub, Inc (Filed With SEC on December 22, 2020)

Voting Agreement, dated as of December 21, 2020, by and among ImmunityBio, Inc., NantKwest, Inc., and the NantKwest, Inc. stockholders party thereto (Filed With SEC on December 22, 2020)

Voting Agreement, dated as of December 21, 2020, by and among NantKwest, Inc., ImmunityBio, Inc. and the ImmunityBio, Inc. stockholders party thereto (Filed With SEC on December 22, 2020)

COVID Joint Development, Manufacturing and Marketing Agreement between NantKwest, Inc. and ImmunityBio, Inc., dated August 21, 2020 (Filed With SEC on November 9, 2020)

First Amendment to Facility License Agreement by and between NantWorks, LLC and NantKwest, Inc., dated September 14, 2020 (Filed With SEC on November 9, 2020)

Sublease Agreement between Altor Bioscience Manufacturing Company, LLC and NantKwest, Inc., dated September 30, 2020 (Filed With SEC on November 9, 2020)

Offer Letter between the Company and Richard Adcock, dated October 26, 2020 (Filed With SEC on November 9, 2020)

Underwriting Agreement, dated June 24, 2020 (Filed With SEC on June 25, 2020)

First Amendment to the July 1, 2019 Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated March 31, 2020 (Filed With SEC on May 11, 2020)

Description of the Registrants Securities (Filed With SEC on March 25, 2020)

Cost Allocation Agreement between the Company and ImmunityBio, Inc. and its subsidiaries, dated January 29, 2020 (Filed With SEC on March 25, 2020)

Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated July 5, 2019 (Filed With SEC on August 6, 2019)

Amended and Restated 2015 Equity Incentive Plan and forms of award thereunder (Filed With SEC on June 7, 2019)

Letter Agreement with Barry Simon dated May 3, 2018 (Filed With SEC on August 6, 2018)

Offer of Employment Letter with Sonja Nelson dated June 11, 2018 (Filed With SEC on August 6, 2018)

COMMERCIAL LEASE (Filed With SEC on November 10, 2016)

AMENDED AND RESTATED SHARED SERVICES AGREEMENT (Filed With SEC on August 15, 2016)

NantKwest Inc. | 9920 Jefferson Blvd, Culver City, CA 90232 www.nantkwest.com (Filed With SEC on May 16, 2016)

3530 John Hopkins Court, San Diego, CA 92121 Main: (858) 633-0300 Fax: (858) 380-1999 www.NantKwest.com (Filed With SEC on March 30, 2016)

SHARED SERVICES AGREEMENT (Filed With SEC on March 30, 2016)

FACILITY LICENSE AGREEMENT (Filed With SEC on March 30, 2016)

JOINTDEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on July 27, 2015)

LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND FOX CHASE CANCER CENTER (Filed With SEC on July 27, 2015)

RUSH- ZELLERX LICENSE AGREEMENT (Filed With SEC on July 27, 2015)

LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN (Filed With SEC on July 27, 2015)

LEASE AGREEMENT (Filed With SEC on July 27, 2015)

SUBLEASE (Filed With SEC on July 27, 2015)

LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN (Filed With SEC on July 27, 2015)

NANTKWEST, INC. [ ] Shares of Common Stock, par value $0.0001per share Underwriting Agreement (Filed With SEC on July 16, 2015)

NANTKWEST, INC. 2015EQUITY INCENTIVE PLAN (Filed With SEC on July 15, 2015)

CONKWEST, INC. EXECUTIVE INCENTIVE COMPENSATION PLAN Adopted by the Board of Directors on July 13, 2015 and effective immediately prior to the Companys initial public offering (Filed With SEC on July 15, 2015)

AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 15, 2015)

LEASE AGREEMENT (Filed With SEC on July 13, 2015)

CONKWEST, INC. 2533 SouthCoast Highway 101, Suite 210 Cardiff by the Sea, CA 92007 June 18, 2015 (Filed With SEC on June 19, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 19, 2015)

CONKWEST, INC. SUBSCRIPTION AND SECURITIES PURCHASE AGREEMENT UNITS (Filed With SEC on June 19, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 19, 2015)

CONKWEST, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on June 19, 2015)

CONKWEST, INC. 2014 EQUITYINCENTIVE PLAN (Filed With SEC on June 19, 2015)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 19, 2015)

AGREEMENT (Filed With SEC on June 19, 2015)

JOINTDEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on June 19, 2015)

LICENSE AGREEMENT BY AND BETWEEN CONKWEST, INC. AND INTREXON CORPORATION February 23, 2010 Table of Contents (Filed With SEC on June 19, 2015)

UHN- ZelleRx LICENSE AGREEMENT (Filed With SEC on June 19, 2015)

LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND FOX CHASE CANCER CENTER (Filed With SEC on June 19, 2015)

RUSH- ZELLERX LICENSE AGREEMENT (Filed With SEC on June 19, 2015)

LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN (Filed With SEC on June 19, 2015)

CONKWEST, INC. Warrant (Filed With SEC on June 19, 2015)

COMMON STOCK PURCHASE WARRANT CONKWEST, INC. (Filed With SEC on June 19, 2015)

CONKWEST, INC. Stock Purchase Warrant (Filed With SEC on June 19, 2015)

GENOMIC AND PROTEOMIC SERVICES AGREEMENT (Filed With SEC on June 19, 2015)

Category

Industry

Companies

Contracts

NantKwest, Inc. Contracts & Agreements